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ABSTRACT 
Objective: The objective of this research work is to develop and evaluate the mucoadhesive gastroretentive tablets of an anti – ulcer drug for 
sustain release. Materials and Methods: Mucoadhesive tablets were prepared by direct compression method using Hydroxy propyl methyl 
cellulose K4M, Carbopol 940 NF and Guar gum in the various drug – polymer ratios.  The prepared tablets were evaluated for their pre and post 
compression parameters. In this study the optimized formulation was obtained within the specified limits. Results: The final optimized 
formulation was showed mucoadhesion time 12 h, mucoadhesive strength of tablets were ready with HPMC K4M, Carbopol 940 NF and gum 
were found to be 45 g and the extreme proportion of drug release was obtained 97.11% at the completion of 12 h. The drug release mechanism 
for optimized formulations of pantoprazole mucoadhesive sustain release tablets was observed to be zero order kinetic model. Conclusion: The 
formulation of hydroxy propyl methyl cellulose showed excellent mucoadhesive ability and a suitable drug release pattern.  
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INTRODUCTION 
Mucoadhesive tablets have an advantage of increasing the 
residence time and much additional intimate contact with 
the mucus layer and reduction in frequency of drug 
administration. Mucoadhesive polymers are water-soluble 
polymers, which are swellable network, linked by cross 
linking agents1. These polymers have ideal polarity to make 
that they permit adequate wetting by the mucus and optimal 
fluidity that permits the mutual absorption and 
interpenetration of polymer and mucus. The effective study 
was made to formulate the mucoadhesive tablets of 
pantoprazole sodium sesquihydrate as a model drug whose 
half-life is 1hour. Mucoadhesive sustained release systems 
increase the effectiveness of drug by maintaining the drug 
concentration in therapeutic level and permitting targeting 
and localization of medication at specific site. The period of 
contact and intimacy between polymer-drug particles 
and tissue layer surface is accrued by mucoadhesion. The 
pantoprazole could be a proton pump inhibitor, belongs 
to group of benzimidazole, used for the treatment 
of gastric and duodenal ulcers 2, 3. In this research work 
pantoprazole sodium sesquihydrate mucoadhesive 
gastroretentive tablets are formulated and evaluated. 
MATERIALS AND METHODS  
Materials 
Pantoprazole sodium sesquihydrate was obtained as gift 
sample from Aurobindo Laboratories Pvt Ltd, Hyderabad. 
Hydroxy propyl methyl cellulose K4M, Carbopol 940 NF, 
Guar gum, Avicel PH 102, PVP K30, Magnesium stearate and 
Aerosol were obtained from Kerry laboratories Pvt Ltd. 
Drugs and excipients compatibility study 
Tablet dosage form of the drug is intimate contact with some 
excipients that could result the stable of the drug. Mixture of 
drug and excipients were prepared and evaluated. 
Formulation of Pantoprazole sodium sesquihydrate 
mucoadhesive tablets 4, 5 
The procedure for the preparation was direct compression 
and different formula was used in the formulation shown in 
table 2. All ingredients were mixed with various ratios for 
each formulation for binders, disintegrants. Finally, dye was 
added together with magnesium stearate and talc, later the 
powder mixture was punched with rotary punch tableting 
machine using 12 mm punches. 
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Table 1: Formula for making of Pantoprazole sodium sesquihydrate sustain release mucoadhesive tablets 
Ingredients F1 F2 F3 F4 F5 F6 F7 F8 F9 
Pantoprazole sodium 
sesquihydrate(mg) 
40 40 40 40 40 40 40 40 40 
Hydroxypropyl methyl 
cellulose K4M(mg) 
20 30 40 _ _ _ _ _ _ 
Carbopol 940NF(mg) _ _ _ 20 30 40 _ _ _ 
Guar gum(mg) _ _ _ _ _ _ 20 30 40 
AvicelPH  102/MCC(mg) 80 70 60 80 70 60 80 70 60 
Poyvinyl pyrrolidone 
K30(mg) 
55 55 55 55 55 55 55 55 55 
Magnesium stearate 
2%(mg) 
4 4 4 4 4 4 4 4 4 
Aerosil/colloidal silicon 
dioxide(mg) 
Qs Qs Qs Qs Qs Qs Qs Qs Qs 
    Total(mg) 200 200 200 200 200 200 200 200 200 
 
Micromeritic properties: 1, 4, 5  
Bulk density 
Bulk density was measured by presieved drug excipient 
mixture into a graduated cylinder and measuring the volume 
(Vo) and weight (M) 
Bulk density = M/Vo. 
Tapped density  
Tapped density is set by putting a graduate containing 
comparable form of residue by  manual tapping for a set 
variety of 100 faucets till powder bed volume was touched a 
minimum. 
Tapped density = mass of powder / minimum volume of 
powder. 
Angle of repose 
This can be the utmost angle attainable between the external 
of a heap of residue and also the horizontal plane. Adequate 
amount of mixture of API powder were well-versed a funnel 
from a specific height (2cm) onto a flat surface till it 
fashioned a heap, that touched the tip of the funnel. It was 
measured the heap crest. Angle of repose () = Tan-¹(h/r) 
Evaluation of Mucoadhesive Tablets 6, 7 
All formulations were evaluated for various parameters such 
as hardness, thickness, friability, disintegration time, drug 
release in vitro dissolution studies, mucoadhesion time and 
strength, in vitro wash off test and swelling index. 
Thickness  
Vernier callipers was determined the tablets thickness. 
Every batch 3 tablets were used, and calculated average 
values. Tablet thickness ought to be controlled at intervals a 
± 5th variation of standard worth.  
Hardness  
The prepared tablets were subjected to hardness test.  
Friability  
The friability decided victimisation Roche friabilator stated 
in %. 20 tablets were weighed and located in chamber. in 
line with guideline friabilator was started at 100 times for 4 
minutes. And tablets were exposed for mutual influence of 
scrape and shock result of the malleable cavity ringing the 
tablets drops them at an aloofness of 6 inches with each 
revolution. The tablets were then dusted and reweighed and 
also the part of friability was calculated by victimisation the 
subsequent formula 
% Friability =Iinitial weight–final weight/initial weight x100 
Weight variation test 
20 tablets were designated indiscriminately from the heap, 
weighed on an individual basis and also the average weight 
was determined. The % deviation of every tablets weight 
against the typical weight was calculated. The best 
necessities are met, if no more than 2 of the individual 
weights deviate from the typical weight by quite fifth and 
none deviates more than 10%. Weight variation IP limits just 
in case of consideration of tablets more than 80 mg 
however less than 250 mg is ± 7.5%. 
Disintegration test(USP)  
The USP device to check disintegration uses 6 glass tubes 
that are three longs open at the highest and ten mesh screens 
at the bottom end. to check for disintegration time, one 
tablet is placed in every tube and also the basket rack is 
positioned in a very one l beaker of water, 0.1N HCl answer 
at 37±2°C specified the2.5 cm tablet remains below the 
surface of liquid on their upward movement and not 
nearer than 2.5 cm from the underside of the beaker in their 
downward movement. Passage the basket encompassing the 
tablets awake and bottom into of 5-6 cm a distance at a 
frequency of 28 to 32 cycles per minute. Floating of the 
tablets is prevented by inserting perforated plastic discs 
on every tablet. According to the test the tablet should 
disintegrate and every one particle should pass through the 
10mesh screen in the time fixed. If any residues remain, 
it should have a soft mass. Disintegration time 
for uncoated tablets is 5 - 30 minutes, for coated tablets 1-
2 hours. 
Content of drug 
The ready pantoprazole Na sesquihydrate tablets were 
tested for their drug content 
From the prepared tablets of each batch one tablet were 
taken and it absolutely was dissolved in 100 ml of 0.1N 
HCl during a 100 ml meter flask and therefore the solution 
was filtered. 1 ml of the filtrate was more diluted to 10 ml 
with 0.1N HCl. Absorbance of the ensuing solution was 
measured by UV- visible spectrophotometer at 282 nm. 
In vitro drug dissolution studies7,  8 
The USP dissolution equipment kind II was used to review 
the in vitro drug unleash from numerous formulations ready. 
The dissolution medium used was 900 ml of acidic buffer 
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of hydrogen ion concentration 0.1N HCl for 12 h. 
the tablet was unbroken in to the basket. Maintained the 
temperature at 37°C ± 0.5°C and therefore the stirring rate 
was 50 rpm. At regular time intervals Samples were 
withdrawn and therefore the same volume was replaced 
with recent dissolution medium. And performed in vitro 
dissolution studies of marketed delayed enteric coated 
pantoprazole sodium, USP, 40 mg. This was additionally 
performed with the hydrogen ion concentration 0.1NHCl for 
two hours so placed the hydrogen ion concentration 6.8 
phosphate buffer for 10 hours. The samples were measured 
by ultraviolet light – visible spectrophotometer at 282 nm. 
Swelling index studies 
Swelling of excipients of mucoadhesive dose type involves 
the absorption of a liquid leading to associate degree 
increase in weight and volume. Liquid uptake by the 
particle could also be because of saturation of 
capillary areas inside the particles or association of molecule. 
The liquid enters the particles through pores and bind 
to giant molecule, breaking the chemical bond and leading 
to the swelling of particle. the extent of swelling is 
often measured in terms of proportion (%) weight gain by 
the mucoadhesive dose type. technique the swelling study of 
various formulations were disbursed mistreatment USP 
dissolution equipment (rotating paddle) II at 37± 0.5°c 
rotating at a 50rpm mistreatment 0.1n HCl for 12 hours. The 
0.1N 
HCl resolution was ready by mistreatment 8.5 millilitre of 
HCl in a thousand millilitre of water. before the swelling 
index (wo) in this study individual weight tablet was taken, 
the tablets were unbroken during a basket, tablet was 
removed each 1hour interval up to twelve hours, excess 
water was removed mistreatment filter paper. Reweighed at 
time 't' the swollen tablets. 
Swelling index = (wt. – wo) / wo x 100 
where, wo = tablet initial weight, wt. = swollen tablet weight 
at time 't'. 
In vitro mucoadhesive strength  
The changed physical balance methodology by resolve the 
mucoadhesive capability of all formulations. The changed 
double beam physical balance equipment consists of proper 
pan in lower finish has been connected with copper wire by 
a glass slide. 3.8 cm diameter a glass vial and a height of two 
cm was unbroken in a beaker stuffed with media HCl 
of pH 0.1 N, below right side of the balance that was then 
placed. model membrane Goat stomach membrane 
wetting fluid media for pH 0.1N HCl.  The abdomen 
membrane thickness used in between from 1.3 to 2.5 mm. It 
was to a glass slide abdomen membrane tried and slide 
was mounted over the protrusion within the 2sided 
adhesive glass ampule employing a thread. The in an 
exceedingly glass beaker glass block was then unbroken. The 
beaker was stuffed with 0.1N HCl up to the side of the 
goat abdomen membrane to keep up abdomen membrane 
viability throughout the experiments. The one side of the 
tablet was connected to the glass slide of the proper arm of 
the balance so beaker was raised slowly till contact between 
goat membrane and mucoadhesive pill was established and 
extra weight, to make the proper side weight equal with 
left side pan. A preload of five g was placed on the slide for 
five min between mucoadhesive tablet and goat abdomen 
membrane. The preload and preload time were unbroken 
constant for all formulations. Next, water was dropped into 
the beaker at a speed of 2 ml.min-1 till the tablet. The 
addition of water was stopped once mucoadhesive tablet 
containing water was weighed and therefore the minimum 
detachment force was calculated consequently. The 
detachment force in gram (g) was transformed into Newton 
(N, force of adhesion) by employing a factor (1 g = 
0.009806N).  
Adhesion force (N) = Strength of Mucoadhesion x 9.81 
                                                       1000 
RESULTS AND DISCUSSION 
Compatibility study between drug and polymer by FTIR 
The FTIR method was to study the compatibility between the 
drug and polymer. The pantoprazole sodium sesquihydrate 
showed characteristic bands at 3484.7 cm-¹ for N-H 
stretching, 2996 cm-¹ for C-H bending, 1377cm-¹ for C-N 
stretching, 1037cm-¹ for C-H bending.  
On performed pure drug and drug with polymer mixture all 
the characteristic peaks of drug were found to be similar IR 
spectra of drug polymer mixture showed the suitability of 
the polymers used for the preparation of mucoadhesive 
tablets. These are shown in figures 1, 2, 3. 
 
 
Figure 1: FTIR Spectrum of Pantoprazole sodium sesquihydrate with HPMC K4M 
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Figure 2: FTIR Spectrum Pantoprazole sodium sesquihydrate with Carbopol 
 
 
Figure 3: FTIR spectrum of Pantoprazole sodium sesquihydrate with Guar gum  
 
Table 2: physicochemical evaluation of pantoprazole sodium sesquihydrate mucoadhesive tablets. 
All the micromeritic properties are within the IP standards. 
Batch code Thickness 
(mm) 
Hardness 
(kg/cm²) 
Friability (%) Weight 
variation(mg) 
Drug content 
(%) 
F1 0.42 4.8±0.28 0.13±0.06 199±0.14 98.75 
F2 0.48 4.6±0.67 0.14±0.05 198±0.23 98.56 
F3 0.46 5.3±0.65 0.01±0.08 197±0.37 98.52 
F4 1.14 4.5±0.53 0.51±0.05 199±0.65 97.95 
F5 1.16 4.7±0.74 0.27±0.75 199±0.43 96.68 
F6 1.24 4.9±0.61 0.09±0.06 198±0.10 97.23 
F7 1.68 4.4±0.53 0.07±0.03 199±0.38 97.69 
F8 1.75 4.9±0.71 0.17±0.08 198±0.63 99.03 
F9 1.56 4.9±0.65 0.48±0.06 197±0.93 98.89 
Mean ±standard deviation (n=3)   
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Table 3:  Micromeritic properties of Pantoprazole SS powder blend 
Batch 
code 
Bulk density 
(gm/ml) 
Tapped 
density(gm/ml) 
Carr's index 
(%) 
Hausner's 
ratio 
Angle of 
repose(Ɵ) 
F1 0.31±0.01 0.32±0.03 11.03±0.06 1.06±0.04 25.02±0.13 
F2 0.32±0.04 0.35±0.01 11.21±0.05 1.03±0.03 25.05±0.16 
F3 0.35±0.05 0.34±0.04 11.35±0.07 1.04±0.02 25.19±0.21 
F4 0.36±0.09 0.37±0.09 12.04±0.06 1.07±0.13 26.03±0.01 
F5 0.39±0.06 0.38±0.17 14.05±0.24 1.08±0.21 26.08±0.04 
F6 0.38±0.08 0.39±0.21 15.09±0.14 1.13±0.02 27.15±0.08 
F7 0.41±0.13 0.42±0.34 16.13±0.25 1.19±0.05 28.21±0.37 
F8 0.43±0.34 0.43±0.18 16.34±0.33 1.21±0.07 28.19±0.28 
F9 0.45±0.05 0.46±0.35 18.31±0.12 1.24±0.06 30.58±0.32 
Mean±standard deviation (n=3) 
 
Ex vivo mucoadhesive strength  
The mucoadhesive strength of different formulations (F1 to 
F9) were evaluated. Mucoadhesive strength of formulation is 
depending on the various polymers used and concentration 
of polymers used and without causing any irritation to the 
mucosal surface. Tablets of formulation   F5 shows least 
adhesion force than tablets of all other formulations, which 
might be due to low viscosity of Carbopol (940 NF). The 
highest adhesion force i.e. highest strength of the 
mucoadhesive bond was observed with the formulation F3 
containing only HPMC, therefore that indicates bio adhesive 
strength of HPMC is much more than that of the Carbopol.  
 
Table 4: Mucoadhesive study of pantoprazole mucoadhesive formulations (F1 to F9) 
Formulation code Mucoadhesive strength(g) Mucoadhesive force (N) 
F1 45 0.44 
F2 42 0.41 
F3 46 0.45 
F4 25 0.24 
F5 24 0.23 
F6 25 0.24 
F7 30 0.29 
F8 34 0.33 
F9 35 0.32 
 
 
Swelling index studies 
Swelling index of all formulations is shown in Table 6. 
swelling index was calculated with respect to time. Bio 
adhesion and drug release profile are reliant on the swelling 
nature of the tablets. Swelling index increased as the weight 
improvement by the tablets increased proportionally with 
the rate of hydration as shown in figure 3. The highest 
hydration (swelling) i.e. 97.47% was observed with the 
formulation F3 HPMC3. This indicates that the rapid 
hydration of polymer used (HPMC K4M). The swelling rate of 
tablets increased as the concentration of polymer in the 
tablet increased. It was detected that HPMC K4M was able to 
give the higher swelling index than the Carbopol 940 and 
guar gum. 
 
Table 5: Swelling index of different formulations (F1toF9) of pantoprazole sodium sesquihydrate mucoadhesive sustain 
release table. 
Time 
(hrs) 
F1 HPMC1 F2 HPMC2 F3 HPMC3 F4 
CARB1 
F5 
CARB2 
F6 
CARB3 
F7 
GG1 
F8 
GG2 
F9 
GG3 
0 0 0 0 0 0 0 0 0 0 
1 47.25 51.75 53.17 70.21 69.75 66.15 60.72 63.26 65.25 
2 51.67 53.01 57 78.04 73.39 70.19 64.13 65.43 68.17 
3 54 55.34 61.45 79.56 76.47 76.25 66.24 67.09 70.02 
4 57.3 56 67.5 80.14 79.05 79.36 69.43 69.45 73.42 
5 58.12 57.45 71.63 83.44 81.08 81.62 70.45 71.63 75 
6 60.1 62.1 75.38 86.67 84 84.23 72.58 75.41 78.05 
7 61.32 65.13 78.58 89.43 87.09 87.58 75.29 78.28 81.21 
8 64 68.45 84.69 91.39 90.62 90.62 78.49 81.56 84.19 
9 68 70.37 95.39 92.37 92.85 92.79 81.62 84.29 87.57 
10 78 88.05 97.47 94.51 95.16 96.91 85.57 88.38 91.39 
Mean±standard deviation (n=3) 
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Figure 4: Swelling index of various formulations (F1 to F9) of mucoadhesive pantoprazole sodium 
sesquihydrate tablets. 
 
In vitro drug release studies 
At 10th hr the cumulative percent drug release for HF1, HF2 
and HF3formulations was found to be 85.72%, 87.18%. 
97.29% respectively. For CF4, CF5, CF6 formulations, the 
percentage cumulative drug release was in the order of 
86.42%, 84.49%, 81.67% respectively and for GF7, GF8, F9 
formulations, the percentage cumulative drug release was in 
the order of 86.53%, 88.45%, 89. 43% respectively. Among 
all the formulations (HF1 to HF3) hydroxy propyl methyl 
cellulose tablets showed increased and sustained drug 
release. HF3 showed increased amount of percentage drug 
release due to increased drug polymer ratio and the swelling 
and diffusion. 
The percentage drug release for Carbopol was less than 
HPMC tablets of pantoprazole sodium sesquihydrate may be 
due to its high viscous and mucoadhesive nature. The 
percentage cumulative drug release for Guar gum tablets 
was less than HPMC tablets but greater than Carbopol tablets 
due to its high mucoadhesion nature. 
Therefore, among all the formulations, HF3 was chosen for 
further study due to its increased drug release. 
       
 
Table 6: In vitro drug release of pantoprazole SS from formulation (F1 to F9). 
Time 
(hrs) 
HF1 HF2 HF3 CF4 CF5 CF6 GF7 GF8 GF9 
0 0 0 0 0 0 0 0 0 0 
1 11.12 
±0.06 
14.15 
±0.08 
20.05 
±0.29 
23.05 
±0.02 
25.55 
±0.78 
27.19 
±0.10 
10.65 
±0.37 
9.43 
±0.24 
17.65 
±0.37 
2 20.34 
±0.19 
23.12 
±0.06 
27.09 
±0.05 
34.25 
±0.14 
35.62 
±0.14 
31.75 
±0.43 
17.69 
±0.39 
20.56 
±0.32 
31.67 
±0.38 
3 34.45 
±0.25 
34.24 
±0.13 
35.65 
±0.37 
39.56 
±0.32 
47.29 
±0.16 
37.47 
±0.27 
34.67 
±0.84 
35.34 
±0.19 
42.72 
±0.41 
4 45.67 
±0.38 
38.72 
±0.41 
43.36 
±0.20 
45.65 
±0.37 
52.49 
±0.28 
41.29 
±0.16 
38.75 
±0.43 
39.67 
±0.38 
54.67 
±0.38 
5 56.12 
±0.06 
46.67 
±0.38 
49.68 
±0.39 
57.43 
±0.24 
63.75 
±0.43 
47.43 
±0.73 
46.43 
±0.24 
42.47 
±0.27 
67.35 
±0.20 
6 62.42 
±0.24 
58.12 
±0.05 
69.09 
±0.05 
66.75 
±0.43 
68.58 
±0.33 
53.59 
±0.80 
62.45 
±0.25 
48.29 
±0.16 
73.65 
±0.37 
7 68.16 
±0.09 
69.71 
±0.40 
78.04 
±0.02 
72.46 
±0.26 
70.54 
±0.31 
58.55 
±0.78 
73.65 
±0.37 
59.42 
±0.24 
78.57 
±0.32 
8 75.72 
±0.41 
76.52 
±0.30 
87.25 
±0.14 
77.37 
±0.21 
74.86 
±0.49 
65.47 
±0.27 
81.64 
±0.39 
70.48 
±0.27 
80.44 
±0.25 
9 78.56 
±0.32 
81.82 
±0.47 
95.05 
±0.02 
81.33 
±0.19 
78.43 
±0.24 
77.19 
±0.63 
83.48 
±0.27 
78.56 
±0.32 
84.39 
±0.22 
10 85.72 
±0.41 
87.18 
±0.10 
97.29 
±0.16 
86.42 
±1.71 
84.49 
±0.28 
81.67 
±0.38 
86.53 
±0.30 
88.45 
±0.25 
89.34 
±0.19 
Mean±standard deviation (n=3) 
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Figure 5: Cumulative percentage drug release for mucoadhesive tablets of pantoprazole sodium sesquihydrate (F1 to F9). 
 
Table 7: Drug release kinetics data for mucoadhesive tablets of pantoprazole sodium sesquihydrate (F3) 
Formulation code Zero order 
R² 
First order 
R² 
Higuchi diffusion kinetics 
R² 
Korsmeyer peppas 
R² 
F3 0.984 0.869 0.936 0.959 
 
 
Figure 6: Zero order Equation for mucoadhesive tablets 
of pantoprazole sodium sesquihydrate (HF3) 
 
CONCLUSION 
The present work was concluded to develop a mucoadhesive 
drug delivery system using three different grades of 
polymers of hydroxy propyl methyl cellulose K4M, Carbopol 
940 NF and Guar gum, in different concentrations. The 
optimized formulation F3 showed excellent mucoadhesive 
ability and a suitable sustained drug release pattern. The 
developed gastroretentive drug delivery system provides 
advantages of ease of preparation and sustained drug 
release. 
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